 |
Mitoxantrone HCl |
|---|---|
| Trade Name | Novantrone |
| Orphan Indication | Acute myelogenous leukemia, also referred to as acute nonlymphocytic leukemia |
| USA Market Approval | USA |
| USA Designation Date | 1987-07-13 00:00:00 |
| Sponsor | Lederle Laboratories;Division of American Cyanamid Company, 401 N. Middletown Road;Pearl River, New York, 10965 |
